Dr. Michael D Gabbard Ii, M.D. Orthopaedic Surgery - Adult Reconstructive Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1115 Ronald Reagan Pkwy Ste 148, Avon, IN 46123 Phone: 317-817-1636 |
Dr. Mark D Webster, MD Orthopaedic Surgery Medicare: Medicare Enrolled Practice Location: 1115 Ronald Reagan Pkwy, Suite 148, Avon, IN 46123 Phone: 317-274-7273 Fax: 317-278-5494 |
News Archive
With rising concern over the cost of the new Medicare prescription drug benefit program – going into effect January, 2006 and estimated to cost $593 billion over the next decade – a new UCSF study reveals that a key cost-cutting strategy employed by HMOs for 15 years is simply not working.
Amgen today announced that the U.S. Food and Drug Administration (FDA) approved two new indications for Prolia® (denosumab) as a treatment to increase bone mass in women at high risk for fracture receiving adjuvant aromatase inhibitor therapy for breast cancer and as a treatment to increase bone mass in men at high risk for fracture receiving androgen deprivation therapy for non-metastatic prostate cancer.
Forest Laboratories, Inc., an international pharmaceutical manufacturer and marketer, today announced that it has been granted European Medicines Agency (EMA) approval to market Colobreathe dry powder colistimethate sodium for inhalation for treating cystic fibrosis patients aged 6 years and older with chronic lung infection caused by P. aeruginosa.
Long-duration spaceflight may have a long-term negative impact on bone health, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Atlanta.
› Verified 3 days ago